Acurx Pharmaceuticals, Inc. (ACXP) earnings
Quarterly results of Acurx Pharmaceuticals, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Next earnings date
Acurx Pharmaceuticals, Inc. was expected to report around November 11, 2026; nothing is on file with the SEC yet.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Acurx Pharmaceuticals, Inc. reported revenue of - and a net loss of $2.3M.
Diluted earnings per share were -$0.53.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$2.3M | -$0.53 |
| Q1 FY2026 | - | - | -$1.7M | -$0.62 |
| Q4 FY2025 | - | - | -$1.6M | - |
| Q3 FY2025 | - | - | -$2M | -$1.23 |
| Q2 FY2025 | - | - | -$2.2M | -$1.89 |
| Q1 FY2025 | - | - | -$2.1M | -$2.15 |
| Q4 FY2024 | - | - | -$2.8M | - |
| Q3 FY2024 | - | - | -$2.8M | -$3.45 |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Annual report 10-K
- Quarterly report 10-Q
When is Acurx Pharmaceuticals, Inc.'s next earnings date?
Acurx Pharmaceuticals, Inc. was expected to report around November 11, 2026; nothing is on file with the SEC yet.
Get an email when ACXP reports
Follow ACXP and we email you its next results the day they are filed, with the numbers explained.